Company Quick10K Filing
⚲
MamaMancini's Holdings
Filings
10-Q 2021-04-30 Filed 2021-06-14
10-K 2021-01-31 Filed 2021-04-21
10-Q 2020-10-31 Filed 2020-12-14
10-Q 2020-07-31 Filed 2020-09-14
10-Q 2020-04-30 Filed 2020-06-15
S-1 2020-02-07 Public Filing
10-K 2020-01-31 Filed 2020-04-23
10-Q 2019-10-31 Filed 2019-12-09
10-Q 2019-07-31 Filed 2019-09-12
10-Q 2019-04-30 Filed 2019-06-14
10-K 2019-01-31 Filed 2019-04-23
10-Q 2018-10-31 Filed 2018-12-11
10-Q 2018-07-31 Filed 2018-09-14
10-Q 2018-04-30 Filed 2018-06-13
10-K 2018-01-31 Filed 2018-05-16
10-Q 2017-10-31 Filed 2017-12-14
10-Q 2017-07-31 Filed 2017-09-14
10-Q 2017-04-30 Filed 2017-06-13
10-K 2017-01-31 Filed 2017-03-23
10-Q 2016-10-31 Filed 2016-12-15
10-Q 2016-07-31 Filed 2016-09-13
10-Q 2016-04-30 Filed 2016-06-13
10-K 2016-01-31 Filed 2016-04-21
10-Q 2015-10-31 Filed 2015-12-11
10-Q 2015-07-31 Filed 2015-09-14
10-Q 2015-04-30 Filed 2015-06-12
10-K 2015-01-31 Filed 2015-05-01
10-Q 2014-10-31 Filed 2014-12-22
10-Q 2014-07-31 Filed 2014-09-08
10-Q 2014-04-30 Filed 2014-06-12
10-K 2013-12-31 Filed 2014-03-20
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-09
10-Q 2012-12-31 Filed 2013-01-23
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-11-13
10-K 2012-06-30 Filed 2012-09-24
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-12-31 Filed 2012-02-06
10-Q 2011-09-30 Filed 2011-11-09
Reports
8-K 2020-06-16
8-K 2020-05-06
8-K 2019-05-01
8-K 2019-01-04
8-K 2018-09-17
8-K 2018-01-22

MamaMancini's Holdings Financials

MMMB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin
Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)
Balance Sheet ($'000)2011-09-302012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash0022,00806681841,9181,7421,080115216855400397387587502264655667436639559581479347460609687635611
Accounts Receivable4648146451,0601,0641,1441,0542,3122,2331,2651,2161,3791,4771,7251,3601,8711,8182,3023,0652,8593,0853,7821,7503,2232,6992,3362,7113,298
Inventory779991511124044692133014693303252535074084604441812353618241,1231,2801,0051,3961,4601,4651,651
PP&E40401174859821,1161,2581,2991,3521,4171,4521,5561,5601,5781,7641,7862,0372,2802,3793,3024,5754,9955,5095,6315,6385,9355,9826,095
Assets0022,98202,2121,6304,4035,1245,3944,9756,1326,9365,6755,4485,5055,7946,0915,5326,3476,3196,7507,4737,6207,2728,3576,8127,9577,7649,3469,62610,462
Accounts Payable
Long-Term Debt2194,4014,7734,5685,2004,8834,8455,2825,0295,7505,9885,4615,4905,9705,4135,0115,006
Liabilities364250529556656814078237887112,5684,7734,5664,5005,4965,1715,4474,9645,5835,3205,5326,1736,0359,2079,8868,5139,2548,94610,1569,99910,399
Stockholders' Equity-36-42-482,453-551,5469493,9964,3014,6074,2643,5652,1631,11094996236435687649991,2181,2991,585-1,935-1,528-1,702-1,296-1,182-809-37363
Income Statement ($'000)2011-09-302012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Revenue00001,7721,7002,1683,1022,5832,6653,7603,7473,3532,7393,2383,2733,9244,8244,5765,4105,3577,0057,3517,8297,7425,6418,2437,3658,0999,267
Cost of Revenue1,2821,1861,5432,1801,7801,8282,7052,7272,4082,0912,2562,2512,4492,9662,8923,4423,4584,9954,9914,8394,9133,5795,5554,9345,4086,366
Gross Profit4905156249228038371,0541,0209456489821,0221,4751,8581,6841,9681,9002,0102,3602,9912,8292,0622,6872,3712,6912,901
R&D345719382929232034303137393826252860303732252533
SG&A4113,26431,0962,3573,4622,0041,4681,7621,7742,5421,7831,3911,3061,2691,500615151515152,8082,2451,8952,1201,8662,2162,365
Tax00000000000000000000000000000
Net Income-12-32-1,982-7-611-753-494-1,090-701-793-774-1,792-1,095-1,000-976-441-2264738113312824203-36324-210356356358409
Cash Flow ($'000)2011-09-302012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash Operating-12-3-2,071-2-1,015-1,569-2,575-1,241-1,210-1,180-1,341-1,276-337-427-126-371-438414-123629527-1387262011391,30220867521586
Cash Investing00-180-325-402-849-324-81-142-41-52-65-35-103-4-19-185-22-251-667-170-523-115-420-484-122-243153-74
Cash Financing1244,081101463,3341,3888293581,4831,967-53459219576372-467536-367-90511-284-68179-95028-355-419-37